Respiratory research · 2026
Safety and diagnostic yield of transbronchial lung cryobiopsy in patients with interstitial lung disease and severe pulmonary function impairment.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lederer Christoph, Polke Markus, Reinhard Janna, Eberhardt Ralf, Buschulte Katharina, Eichinger Monika, Heußel Claus Peter, Fuchs Enikő, Kontogianni Konstantina, Allgäuer Michael, Herth Felix J, Trudzinski Franziska C
Аннотация
BACKGROUND: Transbronchial lung cryobiopsy (TBLC) has become an established diagnostic modality in interstitial lung disease (ILD). However, current guidelines frequently exclude patients with severely impaired lung function due to safety concerns. This study aimed to evaluate the safety and diagnostic yield of TBLC in patients with advanced pulmonary function impairment.
METHODS: We conducted a retrospective analysis of consecutive patients with suspected ILD who underwent TBLC for diagnostic evaluation at Thoraxklinik Heidelberg, University Hospital Heidelberg, between November 2017 and December 2021. All cases were reviewed in a multidisciplinary discussion (MDD) before and after biopsy. Severe pulmonary function impairment was defined as a forced vital capacity (FVC) < 50% predicted and/or a diffusing capacity for carbon monoxide (DLCOSB) < 35% predicted. Procedural complications and diagnostic yield were assessed following post-procedural MDD.
RESULTS: A total of 396 patients were included (39% female, mean age 68 ± 12 years), of whom 43 patients (10.9%) had severely physiologically impaired ILD (SPI-ILD). The incidence of pneumothorax did not statistically differ between patients with severe and less physiologically impaired ILD (LPI-ILD) (11.6% vs. 14.7%, p = 0.818), with chest tube placement required in 33 cases overall. Severe bleeding necessitating endoscopic haemostasis occurred in 25.6% of SPI-ILD and 17.8% of LPI-ILD patients (p = 0.218). No surgical interventions for procedure-related complications were required. TBLC contributed to a final diagnosis following MDD review in 318 patients (80%), including 81% in SPI-ILD and 80% in LPI-ILD (p = 1.000).
CONCLUSION: TBLC may represent a viable diagnostic option in carefully selected patients with severely impaired pulmonary function when performed in experienced centres following thorough risk-benefit assessment.
METHODS: We conducted a retrospective analysis of consecutive patients with suspected ILD who underwent TBLC for diagnostic evaluation at Thoraxklinik Heidelberg, University Hospital Heidelberg, between November 2017 and December 2021. All cases were reviewed in a multidisciplinary discussion (MDD) before and after biopsy. Severe pulmonary function impairment was defined as a forced vital capacity (FVC) < 50% predicted and/or a diffusing capacity for carbon monoxide (DLCOSB) < 35% predicted. Procedural complications and diagnostic yield were assessed following post-procedural MDD.
RESULTS: A total of 396 patients were included (39% female, mean age 68 ± 12 years), of whom 43 patients (10.9%) had severely physiologically impaired ILD (SPI-ILD). The incidence of pneumothorax did not statistically differ between patients with severe and less physiologically impaired ILD (LPI-ILD) (11.6% vs. 14.7%, p = 0.818), with chest tube placement required in 33 cases overall. Severe bleeding necessitating endoscopic haemostasis occurred in 25.6% of SPI-ILD and 17.8% of LPI-ILD patients (p = 0.218). No surgical interventions for procedure-related complications were required. TBLC contributed to a final diagnosis following MDD review in 318 patients (80%), including 81% in SPI-ILD and 80% in LPI-ILD (p = 1.000).
CONCLUSION: TBLC may represent a viable diagnostic option in carefully selected patients with severely impaired pulmonary function when performed in experienced centres following thorough risk-benefit assessment.